Sugi Predict

Sugi Predict / Compounds / SCHEMBL247778

SCHEMBL247778

SCHEMBL247778

Cc1cccc(C)c1C(=O)Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.54
▸ L3MBTL1 Q9Y468 3/20 0.45
▸ TDP1 Q9NUW8 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ TYK2 P29597 1/20 0.41
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2A6 P11509 1/20 0.39
▸ TRPA1 O75762 2/20 0.39
▸ ATM Q13315 1/20 0.39
▸ TSHR P16473 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ GPR52 Q9Y2T5 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA7 P43166 1/20 0.38
▸ CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL27753498 0.97 ALDH1A1 (0.52) ALDH1A1L3MBTL1TDP1KDM4EHPGD
SCHEMBL31611275 0.86 ALDH1A1 (0.46) ALDH1A1L3MBTL1TDP1KDM4EHPGD
SCHEMBL476833 0.86 ALDH1A1 (0.71) ALDH1A1L3MBTL1TDP1HPGDTYK2
SCHEMBL27966932 0.86 THRB (0.52) ALDH1A1L3MBTL1KDM4EHPGDHSD17B10
SCHEMBL301550 0.86 ALDH1A1 (0.46) ALDH1A1L3MBTL1TDP1KDM4EHPGD
SCHEMBL12894735 0.84 ALDH1A1 (0.45) ALDH1A1L3MBTL1TDP1KDM4EHPGD
SCHEMBL7539855 0.84 ALDH1A1 (0.45) ALDH1A1L3MBTL1TDP1KDM4EHPGD
SCHEMBL7429144 0.84 ALDH1A1 (0.45) ALDH1A1L3MBTL1TDP1HPGDNPC1
SCHEMBL29766383 0.84 CES2 (0.52) ALDH1A1L3MBTL1TDP1ACHE
SCHEMBL7911668 0.84 CD44 (0.46) ALDH1A1L3MBTL1TDP1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 458 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116333672-B UV (ultraviolet) binder suitable for camera module and preparation method thereof 广东德聚技术股份有限公司 2023-11-17 — — CN claimed
CN-116333672-A UV (ultraviolet) binder suitable for camera module and preparation method thereof 东莞市德聚胶接技术有限公司 2023-06-27 — — CN claimed
CN-113092629-B Purification and isomer detection method of S- (+) -3-hydroxytetrahydrofuran 合肥利夫生物科技有限公司 2022-10-18 — — CN claimed
CN-113092629-A Purification and isomer detection method of S- (+) -3-hydroxytetrahydrofuran 合肥利夫生物科技有限公司 2021-07-09 — — CN claimed
CN-110655594-B Preparation method of monohydroxy sugammadex sodium 江苏海悦康医药科技有限公司 2021-04-30 — — CN claimed
CN-110655594-A Preparation method of monohydroxy sugammadex sodium 江苏海悦康医药科技有限公司 2020-01-07 — — CN claimed
CN-104693062-B Phenylacetylene derivatives and preparation of the side base with ester group, polymerization and methods for using them 哈尔滨工程大学 2017-10-03 — — CN claimed
CN-104910039-A Functional phenylacetylene compound and preparation method thereof UNIV HARBIN ENG 2015-09-16 — — CN claimed
CN-104693062-A Phenylacetylene derivative with ester group on lateral base band and preparation, polymerization and application methods UNIV HARBIN ENG 2015-06-10 — — CN claimed
CN-102423699-B Preparation method of coating-type polysaccharide chiral stationary phase WUHAN INST TECHNOLOGY 2013-08-07 — — CN claimed
EP-2288652-B1 PREPARATION FOR INITIATING RADICAL REACTIONS UNITED INITIATORS GMBH & CO KG (DE) 2012-09-19 — — EP claimed
US-20110272628-A1 Preparation For Initiating Radical Reactions UNITED INITIATORS GMBH (DE) 2011-11-10 — — US claimed
EP-2130858-A1 Preparations to initiate radical reactions Degussa Initiators GmbH & Co. KG (DE) 2009-12-09 — — EP claimed
WO-1993014055-A1 PREPARATION OF 2,5-DICHLOROBENZOPHENONES MAXDEM INCORPORATED (US) 1993-07-22 — — WO claimed
US-5210313-A Friedel crafts aryloylation of 1,4-dichlorobenzene and Lewis acids MAXDEM INCORPORATED (US) 1993-05-11 — — US claimed
US-20250243161-A1 DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS SENSORIUM THERAPEUTICS, INC. 2025-07-31 — — US disclosed
US-20250243177-A1 sGC STIMULATORS CYCLERION THERAPEUTICS, INC. 2025-07-31 — — US disclosed
US-4022900-A Compositions containing 1,2,3,4-tetrahydroisoquinolines used as hypotensive agents MARION LABORATORIES, INC. (US) 1977-05-10 — — US disclosed
US-3965093-A 6-Arylthio penicillanic acid and derivatives thereof E. R. SQUIBB & SONS, INC. (US) 1976-06-22 — — US disclosed
US-3954744-A ANTIBACTERIAL E. R. SQUIBB & SONS, INC. (US) 1976-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250243161-A1 DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS PNMT, HNMT, NNMT ALDH1A1 1109/4885L3MBTL1 1754/4885TDP1 1933/4885
US-20250243177-A1 sGC STIMULATORS GUCY1A1, PTGIS, GUCY1B1 ALDH1A1 1325/4885L3MBTL1 4623/4885TDP1 610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.